Skip to content

Understanding Your Laboratory Test: A Patient's Guide to Testing, Results, and What to Expect

Published: August 9, 2026Updated: August 14, 2026

A blood test that measures how your adrenal glands respond to corticotropin (ACTH) stimulation, primarily used to diagnose adrenal hormone disorders.

Quick summary

{"Measures 17-OHP levels before and after ACTH injection to assess adrenal gland function","Helps diagnose congenital adrenal hyperplasia (CAH) and adrenal insufficiency","Involves blood draw, ACTH injection, and a second blood draw after 30-60 minutes","May help distinguish between different types of adrenal disorders","Results are compared to expected responses to determine normal or abnormal adrenal function"}

Medically reviewed by WellAlly Editorial TeamLast reviewed August 14, 2026Editorial policy

Key facts at a glance

LOINC
101313-5
Short code
17OHP-ACTHstim
Synonyms
17OH-Preg p corticotropin stim pnl SerPl
Category
chemistry
Sample
serum
Container
Serum separator tube (SST) or plain red top tube
Units
N/A
Ref low
30
Ref high
60
Critical range
— – 2000 N/A
Fasting
false
Population
adult
Sex
all
Age range
≥ 18 years
Method
Immunoassay (Chemiluminescence or ELISA) following ACTH stimulation protocol
CPT
82533
SNOMED
414389009
Specimen volume
2-3 mL serum minimum
Stability
Room temperature: 24 hours; Refrigerated (2-8°C): 7 days; Frozen (-20°C): 30 days
Hemolysis max
50
Lipemia max
100
Icterus max
20
TAT
24–72 hours
Order
routine

This diagnostic test is a laboratory procedure that your healthcare provider may order to gather important information about how your body is functioning and to help identify, monitor, or rule out certain medical conditions based on your symptoms and health history.

The 17-Hydroxyprogesterone (17-OHP) after ACTH stimulation test measures the level of 17-OHP in your blood before and after an injection of corticotropin (ACTH), a hormone that stimulates the adrenal glands. This test evaluates how well your adrenal glands respond to ACTH and helps identify certain adrenal gland disorders.

Your doctor may order this test to investigate symptoms you have been experiencing, to screen for potential health problems before they cause noticeable signs, to monitor an ongoing condition or the effectiveness of your treatment plan, or as part of a routine checkup to establish a baseline of your overall health.

This test is primarily used to: 1) Diagnose congenital adrenal hyperplasia (CAH), a genetic condition affecting adrenal hormone production; 2) Evaluate adrenal gland function; 3) Help distinguish between different types of adrenal insufficiency (such as primary adrenal insufficiency Addison's disease vs. secondary adrenal insufficiency); and 4) Screen for CAH in newborns when initial screening is abnormal.

The test is typically performed by collecting a small sample, such as blood drawn from a vein in your arm or urine collected in a sterile container, which is then sent to a laboratory for analysis. The procedure is usually quick, and a trained technician will explain each step and help you stay comfortable throughout the process.

The test involves several steps: First, a blood sample is drawn to measure your baseline 17-OHP level. Then, synthetic ACTH is injected, usually into a muscle or vein. After 30 to 60 minutes, another blood sample is drawn to measure how your 17-OHP levels changed after stimulation. The entire test typically takes 1-2 hours. You may be asked to fast overnight before the test.

Your results will show whether the measured values fall within the normal reference range for your age and sex. Abnormal results do not always indicate a serious problem, since factors such as medications, diet, or recent illness can affect them. Your healthcare provider will review the findings with you and explain what they mean in the context of your overall health.

Normal results show a modest increase in 17-OHP after ACTH stimulation. Significantly elevated 17-OHP levels after stimulation typically indicate congenital adrenal hyperplasia (CAH). Abnormally low or minimal response may suggest adrenal insufficiency. Your healthcare provider will interpret your results based on your symptoms, medical history, and other test results.

Most patients experience very few side effects. You may notice slight bruising, soreness, or a small amount of bleeding where the needle was inserted, which usually resolves within a few days. Serious complications are rare, but you should contact your provider if you experience persistent pain, swelling, or signs of infection at the sample collection site.

Risks are minimal but may include: bruising or bleeding at the injection site, rare infection, dizziness or fainting during blood draw, and rare allergic reaction to the ACTH medication. Some people may experience temporary flushing, headache, or heartbeat changes after the ACTH injection. These effects are usually mild and short-lived.

Reference range

Baseline 17-OHP: <200 ng/dL; Post-ACTH stimulation (30-60 min): Normal response <1000 ng/dL; 21-hydroxylase deficiency suspected: >1500 ng/dLN/A

Specimen: serum

No fasting required. Patient should inform provider of current medications, especially corticosteroids or hormonal contraceptives. Baseline sample drawn, then synthetic ACTH (cosyntropin 250 mcg IV) administered, with repeat sample at 30-60 minutes post-stimulation. Test should be performed in morning due to circadian rhythm effects.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

The ACTH stimulation test for 17-OHP is primarily used to diagnose and differentiate adrenal gland disorders. In congenital adrenal hyperplasia (CAH), 17-OHP levels rise dramatically after ACTH stimulation due to enzyme deficiencies (most commonly 21-hydroxylase deficiency). This test is essential for confirming CAH diagnosis, which is important for proper treatment and genetic counseling. It also helps differentiate between primary adrenal failure and secondary adrenal insufficiency, guiding appropriate treatment strategies.

Frequently asked questions

How should I prepare for this test?
Your healthcare provider may instruct you to fast overnight (usually 8-12 hours) before the test. Inform your provider about all medications you're taking, especially corticosteroids, as they may affect results. Tell your provider if you're pregnant or have any known adrenal conditions. Wear comfortable clothing with easy access to your arm for blood draws.
How long does the test take?
The entire procedure typically takes 1-2 hours. This includes time for the initial blood draw, the ACTH injection, and the second blood draw 30-60 minutes later. You may be asked to remain in the clinic during the waiting period.
Will I need to repeat this test?
Your healthcare provider will determine if repeat testing is necessary based on your initial results and clinical situation. Sometimes the test may be repeated to confirm a diagnosis or monitor treatment effectiveness.
Can I take my regular medications before the test?
Follow your healthcare provider's specific instructions regarding medications. Some medications, especially corticosteroids or hormone therapies, can affect test results. Do not stop taking prescribed medications without consulting your provider.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 14, 2026. · Read our editorial policy